Shervin Badkhshan, MD
Urology · Garden City, NYNPI 1568818805
Payments from drug & device makers
Across 228 payments — averaging $300.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$56K
- Coloplast$11K
- Teleflex LLC$628
- Medtronic$374
- Rigicon,inc.$147
- Palette Life Sciences, Inc.$130
- plus $238 from 3 others
What the payments were for
- Consulting fees$5,0007%
- Grants$50,00073%
- Travel & lodging$4,5147%
- Food & beverage$8,80813%
- Education$1810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 167 | $56,261 |
| Coloplast | 45 | $10,725 |
| Teleflex LLC | 6 | $628 |
| Medtronic | 4 | $374 |
| Rigicon,inc. | 1 | $147 |
| Palette Life Sciences, Inc. | 1 | $130 |
| Antares Pharma, Inc. | 2 | $100 |
| Agiliti Surgical, Inc. | 1 | $98 |
| Endo Pharmaceuticals Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$51,415
- TITAN$2,517
- AMS 700 CXR RTE KIT$639
- UroLift$442
- INTERSTIM$279
- GENERAL KIDNEY STONE DISEASE$153
- RIGI10 MALLEABLE PENILE PROSTHESIS$147
- Barrigel$140
- ADVANCE$140
- Porges Coloplast$137
- GENERAL MALE SUI$131
- Isiris aStent Removal Device$108
How this compares
$68,504 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 41 | $21,540 |
| GemtesaVibegron | 28 | $21,153 |
| Solifenacin Succinate | 75 | $4,780 |
| Tamsulosin Hcl | 285 | $3,594 |
| Finasteride | 72 | $990 |
| Cefpodoxime Proxetil | 11 | $473 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $290 |
| Cefdinir | 15 | $175 |
| Cephalexin | 32 | $121 |
| Levofloxacin | 33 | $101 |
| Doxycycline Hyclate | 11 | $60 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $56 |
Paid to pharmacies, not to this prescriber.
Other urology in Garden City
- Mitchell EfrosGarden City$4.2M
- Jeffrey LumermanGarden City$206K
- Jeffrey SchiffGarden City$198K
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
- Gennady BratslavskySyracuse$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.